Away from the Gleason Score & Towards Quantification of Pattern 4 in Prostate Cancer w/ Dr. Vickers

25 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Dr. Andrew Vickers, PhD, Professor of Healthcare Policy and Research at Weill Cornell Medical College and member of the Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics in New York, NY, delivers a nine-minute presentation on the need for reforming the Gleason score, which remains the cornerstone of decision-making in localized prostate cancer management. He highlights that while the Gleason grading system accurately describes histologic patterns, the scoring system, developed in 1967 and unchanged since, is outdated. Originally designed around six-month survival, it inadequately reflects modern clinical contexts and misrepresents risks, particularly in patients within grade groups 2 to 4.
Dr. Vickers critiques the reliance on ratios of Gleason patterns 3 and 4, which often yield illogical classifications. He emphasizes that the absolute quantity of pattern 4 correlates better with adverse oncologic outcomes, such as metastasis and advanced pathology. Data from multiple institutions, including Memorial Sloan Kettering and international centers, consistently show that quantifying pattern 4 outperforms the Gleason grade group in risk stratification.
Dr. Vikers notes variability among pathologists in measurement methods, limiting standardization. To address this, Dr. Vickers proposes leveraging AI to analyze digitized biopsy slides, refining the quantification process, and identifying optimal predictive models based on oncologic outcomes.

Don't forget to join the GRU Community: https://grandroundsinurology.com/register/
Follow us on Twitter/X: https://x.com/GRUrology
And like and subscribe to us here on YouTube!
Categoria
Oncology
Commenta per primo questo video.

Prossimo